Results 101 to 110 of about 137,068 (205)

Vitamin D to reduce liver fibrosis in non-alcoholic fatty liver disease [PDF]

open access: yes, 2017
BACKGROUND: As the prevalence of metabolic risk factors in the American population has increased over time, so too has the diagnoses of non-alcoholic fatty liver disease (NAFLD).
Fox, Ryan
core  

TRIB3 Is a Hub Gene in Steatohepatitis and Aggravates Lipid Deposition and Inflammation in Hepatocytes

open access: yesDiabetes, Metabolic Syndrome and Obesity
Wen Xia,1,* Li Xiao,1,* Huan Cheng,1 Yuwei Feng2 1Department of Cardiovascular Medicine, Wuhan No.1 Hospital, Wuhan, Hubei, People’s Republic of China; 2Department of Hepatology with Integrated Traditional Chinese and Western Medicine, Hubei No.3
Xia W, Xiao L, Cheng H, Feng Y
doaj  

Clinical Outcomes and Non-Invasive Testing in Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Review. [PDF]

open access: yesLiver Int
Hagström H   +8 more
europepmc   +1 more source

Tongue color tones in Traditional Chinese Medicine correlate with liver histology of metabolic dysfunction-associated steatohepatitis in morbidly obese patients undergoing metabolic and bariatric surgery. [PDF]

open access: yesJ Tradit Chin Med
Zhikang C   +13 more
europepmc   +1 more source

Effect of weight reduction on liver volume in living liver donors with steatosis: a retrospective cohort study. [PDF]

open access: yesAnn Surg Treat Res
Hong K   +10 more
europepmc   +1 more source

Comparison of patients with HCC with and without MASLD after surgical resection. [PDF]

open access: yesJHEP Rep
Ho CJ   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy